The genetic testing
industry, all in one place.
500+ companies, funding rounds, clinical trials, and breakthroughs — tracked daily for founders, investors, and researchers.
500+
Companies tracked
across 8 categories
$12B+
Funding tracked
in VC investment
21+
News published
industry articles
Every Sunday
Weekly digest
Genetic Testing Digest
Browse by category
View all 500 companies →Featured companies
Illumina
Research Tools
Illumina is the world's leading provider of DNA sequencing and array-based technologies, enabling breakthroughs in life science research, translational and consumer genomics, and molecular diagnostics.
Natera
Prenatal Testing
Natera is a global diagnostics company specializing in cell-free DNA testing for prenatal screening, oncology, and organ health, with its flagship Panorama NIPT test used in millions of pregnancies annually.
Recently added
AccuStem
Genetic Testing ·
ActX, Inc.
Genetic Testing ·
Agena Bioscience
Genetic Testing ·
BioCertica
Genetic Testing ·
Carbiotix
Genetic Testing ·
Cellecta, Inc.
Genetic Testing ·
Color
Genetic Testing ·
Fulgent Genetics
Genetic Testing ·
Funding spotlight
AccuStem
Private
ActX, Inc.
Private
Agena Bioscience
Private
BioCertica
Private
Carbiotix
Private
Cellecta, Inc.
Private
Latest news
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
NeoGenomics debuts an FDA-approved PTEN IHC companion diagnostic, expanding precision oncology options for prostate cancer patients.
FDA approves the new Guardant360 Liquid CDx as the largest FDA-approved liquid biopsy panel, dramatically expanding its genomic coverage.
The global DNA diagnostics market is forecast to reach $24.7B by 2034, fueled by precision medicine adoption and rapid genomic advancements.
Every Sunday
The Genetic Testing Digest
Funding rounds, breakthroughs, and precision medicine insights — curated weekly for industry professionals.
Subscribe free →For companies
Reach genomics decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →GRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage
GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.
2026-06-23
ProductNeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
NeoGenomics debuts an FDA-approved PTEN IHC companion diagnostic, expanding precision oncology options for prostate cancer patients.
2026-07-10
ProductGuardant Health's Guardant360 Liquid CDx Earns FDA Approval with 100x Expanded Panel Footprint
FDA approves the new Guardant360 Liquid CDx as the largest FDA-approved liquid biopsy panel, dramatically expanding its genomic coverage.
2026-07-08
500+
Companies
across 8 sectors
$12B+
VC Invested
tracked in our database
3×/week
News published
Mon · Wed · Fri
7+
Articles
in our archive
Companies by sector
16
Consumer
205
Clinical
23
Oncology
8
Pharmacogenomics
18
Prenatal
1
Ancestry
64
Research
25
Genetic
The Genetic Testing Digest
Funding rounds, product launches, research breakthroughs, and the best jobs — curated weekly for the genetic testing industry.
No spam. Unsubscribe anytime.